87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Low-dose plasma treatment shows promise for slowing down tumor growth

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:
Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi
Neurocognitive battery feasible in 3-year-olds during leukemia treatment

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri
Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th
Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3
Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and
Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me
Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t